Literature DB >> 27009322

In vivo imaging of neurodegeneration in dementia with Lewy bodies (DLB).

Chiadi U Onyike1, Gwenn S Smith1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27009322      PMCID： PMC5646266          DOI： 10.1017/S1041610216000156

Source DB:  PubMed          Journal:  Int Psychogeriatr        ISSN： 1041-6102            Impact factor:   3.878


× No keyword cloud information.
  8 in total

1.  Early clinical PET imaging results with the novel PHF-tau radioligand [F-18]-T807.

Authors:  David T Chien; Shadfar Bahri; A Katrin Szardenings; Joseph C Walsh; Fanrong Mu; Min-Ying Su; William R Shankle; Arkadij Elizarov; Hartmuth C Kolb
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Development and screening of contrast agents for in vivo imaging of Parkinson's disease.

Authors:  Krista L Neal; Naomi B Shakerdge; Steven S Hou; William E Klunk; Chester A Mathis; Evgueni E Nesterov; Timothy M Swager; Pamela J McLean; Brian J Bacskai
Journal:  Mol Imaging Biol       Date:  2013-10       Impact factor: 3.488

3.  Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia.

Authors:  Eric M Reiman; Kewei Chen; Gene E Alexander; Richard J Caselli; Daniel Bandy; David Osborne; Ann M Saunders; John Hardy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

4.  Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia.

Authors:  W J Jagust; R P Friedland; T F Budinger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-11       Impact factor: 10.154

5.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.

Authors:  William E Klunk; Henry Engler; Agneta Nordberg; Yanming Wang; Gunnar Blomqvist; Daniel P Holt; Mats Bergström; Irina Savitcheva; Guo-feng Huang; Sergio Estrada; Birgitta Ausén; Manik L Debnath; Julien Barletta; Julie C Price; Johan Sandell; Brian J Lopresti; Anders Wall; Pernilla Koivisto; Gunnar Antoni; Chester A Mathis; Bengt Långström
Journal:  Ann Neurol       Date:  2004-03       Impact factor: 10.422

6.  Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications.

Authors:  G S Smith; M J de Leon; A E George; A Kluger; N D Volkow; T McRae; J Golomb; S H Ferris; B Reisberg; J Ciaravino
Journal:  Arch Neurol       Date:  1992-11

Review 7.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

Review 8.  Neuroimaging characteristics of dementia with Lewy bodies.

Authors:  Elijah Mak; Li Su; Guy B Williams; John T O'Brien
Journal:  Alzheimers Res Ther       Date:  2014-04-09       Impact factor: 6.982
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.